webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

FMOC-L-HYP(BOM)-OH

  CAS No.: 187223-15-0   Cat No.: BADC-01943   Purity: 95% 4.5  

FMOC-L-HYP(BOM)-OH is a dual-protected hydroxyproline used for constructing peptide-based ADC linkers with site-specific reactivity and enzymatic cleavage control.

FMOC-L-HYP(BOM)-OH

Structure of 187223-15-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C28H33N3O8
Molecular Weight
539.58

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(t-butyloxycarbonylaminoethylcarbamoyl)-trans-L-hydroxyproline; Fmoc-Hyp(Bcc)-OH; (4R)-1-Fmoc-4-[[[(2-Boc-amino-ethyl)amino]carbonyl]oxy]-L-proline
IUPAC Name
(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylcarbamoyloxy]pyrrolidine-2-carboxylic acid
Canonical SMILES
CC(C)(C)OC(=O)NCCNC(=O)OC1CC(N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
InChI
InChI=1S/C28H33N3O8/c1-28(2,3)39-26(35)30-13-12-29-25(34)38-17-14-23(24(32)33)31(15-17)27(36)37-16-22-20-10-6-4-8-18(20)19-9-5-7-11-21(19)22/h4-11,17,22-23H,12-16H2,1-3H3,(H,29,34)(H,30,35)(H,32,33)/t17-,23+/m1/s1
InChIKey
PFVAFJSUWCTINJ-HXOBKFHXSA-N
Density
1.35±0.1 g/cm3
Appearance
White to Pink Solid
Quantity
Data not available, please inquire.
Boiling Point
749.0±60.0 °C at 760 mmHg

FMOC-L-HYP(BOM)-OH is a specialized amino acid derivative used extensively in peptide synthesis, particularly in solid-phase peptide synthesis (SPPS). The FMOC (9-fluorenylmethyloxycarbonyl) group is a well-known protective group for the amino terminus of peptides. It allows for the controlled and sequential addition of amino acids while minimizing side reactions. FMOC-L-HYP(BOM)-OH contains hydroxyproline (HYP), a key amino acid found in collagen, which introduces specific structural and functional properties into peptides. This compound is essential in synthesizing peptides that mimic the structure of collagen or other proteins containing hydroxyproline.

The BOM (benzyl oxy methyl) group in FMOC-L-HYP(BOM)-OH is a protecting group for the hydroxyl functionality of hydroxyproline. This protection is crucial during peptide synthesis to prevent unwanted side reactions that could degrade the peptide chain. The BOM group can be selectively removed under mild conditions, typically using hydrogenation, which makes FMOC-L-HYP(BOM)-OH a versatile intermediate for peptides where controlled deprotection is necessary. The BOM group also contributes to the stability of the peptide during synthesis, allowing for more reliable outcomes in complex synthetic processes.

FMOC-L-HYP(BOM)-OH plays a significant role in the synthesis of collagen-like peptides, which are used in various fields such as biomedical research, drug development, and cosmetic formulations. Collagen mimetic peptides are designed to mimic the triple helix structure of natural collagen and are crucial for understanding collagen's role in tissue repair, skin regeneration, and wound healing. By incorporating hydroxyproline residues, FMOC-L-HYP(BOM)-OH helps produce peptides that closely resemble the natural collagen structure, offering insights into collagen-based therapies and biomaterial design.

Another important application of FMOC-L-HYP(BOM)-OH is in the creation of peptides with enhanced stability and bioactivity. Hydroxyproline-containing peptides are often more resistant to enzymatic degradation compared to standard peptides, making them suitable for therapeutic applications that require prolonged stability in biological environments. By using FMOC-L-HYP(BOM)-OH, researchers can synthesize peptides that have improved resistance to proteolysis, which is beneficial in the development of peptide-based drugs or biologics. This property is also valuable for studying peptide-receptor interactions and protein stability.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Benzyl-PEG6-alcohol | Nα-Fmoc-Nγ-Azido-D-2,4-diaminobutyric acid | Boc-ε-azido-Nle-OH | N3-Gly-Gly-OH (DCHA) | N3-L-Orn(Fmoc)-OH | (Me)Tz-butanoic acid | Tetrazine-PEG7-amine hydrochloride | Methyl (2R,4R)-1-Boc-4-hydroxypyrrolidine-2-carboxylate | Methyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride | Boc-L-Tyr(PEG(3)-N3)-OH (DCHA) | FMOC-L-HYP(BOM)-OH
Send Inquiry
Verification code
Inquiry Basket